Wait, we have a special
offer for you!
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Only Available By Prescription
Top brand choice
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Trelegy Ellipta is a prescription for treating chronic obstructive pulmonary disease (COPD). It combines fluticasone furoate, umeclidinium, and vilanterol to reduce inflammation, relax airway muscles, and improve breathing. It is inhaled once daily using an Ellipta inhaler.
Before you plan to buy Trelegy Ellipta for treating COPD, it is crucial to understand its effectiveness, potential side effects, and Trelegy Ellipta price.
COPD, or chronic obstructive pulmonary disease, is a chronic lung condition characterized by persistent airflow limitation that makes breathing difficult. It includes chronic bronchitis and emphysema. While COPD cannot be cured, treatments are available to manage symptoms and slow down its progression.
| Fact Table | |
|---|---|
| Formula | C80H96Cl2F3N2O13S+ |
| License | EU EMA, US FDA |
| Bioavailability | 15.2% |
| Legal status | RX Only |
| Chemical Name | Fluticasone Furoate / Umeclidinium / Vilanterol Trifenatate |
| Elimination half-life | 15.1 hours |
| Dosage (Strength) | 92/55/22mcg (100/62.5/25mcg) (30 doses/inhaler), 200/62.5/25mcg (30 doses/inhaler) |
| Pregnancy | Consult a doctor |
| Brands | Trelegy Ellipta |
| Protein binding | Greater than 99.6% |
| PubChem CID | 122403924 |
| MedlinePlus | a618017 |
| ChEBI | - |
| ATC code | R03AL08 |
| DrugBank | DB08906, DB09076, DB09082 |
| KEGG | D11035 |
| Routes of administration | Topical |
Take Trelegy Ellipta inhalation once daily at the recommended dose.
Use the inhaler at the same time each day to maximize its benefits.
Open the inhaler only when you're ready to use it, as each open-close action prepares a dose.
Rinse your mouth with water after inhaling to reduce the risk of thrush.
If you miss a dose, skip it, and continue your regular schedule. Avoid doubling the dose.
Dispose of any remaining medication in the inhaler after six weeks or as directed.
Fluticasone Furoate, Umeclidinium, and Vilanterol are the active ingredients.
Inform your doctor of any allergies, including fluticasone, umeclidinium, or vilanterol.
Discuss your medical history, especially infections, heart problems, high blood pressure, bone loss, eye problems, difficulty urinating, seizures, overactive thyroid, diabetes, or liver disease.
This medication may increase the risk of infections or worsen existing infections.
If you have recently switched from oral corticosteroids or used high doses of this product, it may affect your body's response to physical stress.
Carry a warning card or medical ID bracelet indicating your use of corticosteroid medications.
Long-term use of this medication may temporarily slow down a child's growth. Regular check-ups are important.
Discuss the use of this medication during pregnancy with your doctor.
Trelegy Ellipta, which contains fluticasone, umeclidinium, and vilanterol, has a wide range of drug interactions and disease interactions. There are 513 known drug interactions categorized as 53 major, 442 moderate, and 18 minor interactions. It is important to review these interactions, especially if you are taking other medications. Additionally, Trelegy Ellipta interacts with 13 different diseases.
Common side effects of the Trelegy Ellipta inhaler may include an upper respiratory tract infection, pneumonia, headache, back pain, joint pain, bone fractures, muscle spasms, thrush, voice changes, cough, sore throat, sinusitis, or a urinary tract infection.
Is Trelegy Ellipta a steroid?
Yes, Trelegy Ellipta contains a steroid component. It is a combination medication that contains three active ingredients: fluticasone furoate, umeclidinium, and vilanterol. Fluticasone furoate is a corticosteroid, which means it has anti-inflammatory properties.
What tier drug is Trelegy Ellipta?
Trelegy Ellipta is considered a higher-tier or specialty medication. It is typically classified as a Tier 3 drug, which means it may have higher out-of-pocket costs than lower-tier medications.
Can Trelegy Ellipta cause weight gain?
Although not very common, weight gain is a possible side effect of Trelegy Ellipta. Since individual responses to medications can vary, some people may experience weight gain while others may not.
How long does it take for Trelegy Ellipta to work?
The time it takes for Trelegy Ellipta to work can vary between individuals. Some people may notice improvements in their symptoms within a few days or weeks, while others may require several weeks or months.
How many doses in Trelegy Ellipta?
A single Trelegy Ellipta inhaler contains 30 doses. Each dose is intended for inhalation once daily, meaning one inhaler will last approximately one month of use.
